Sophie Opdyke, Pharm.D., MBA has been appointed vice president, general manager, Oncology, Ferring Pharmaceuticals. Most recently, she served as vice president, Immuno-Oncology Lead at Pfizer. Ms. Opdyke’s role is Ferring’s first major executive appointment of 2019. She will be responsible for building the U.S. division, leading its day-to-day operations, and shaping its long-term strategic business plan. This includes leading the potential commercial launch of an investigational gene therapy...